Author: admin

GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.

Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 10:30 a.m. PST (12:30 p.m. CST). Immediately following the presentation, Martha will be joined by evp and chief financial officer, Thierry Piéton, to answer questions on the company.

A live webcast of the presentation and Q&A session will be available on January 12, 2026, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the presentation and Q&A session will be available on the same webpage later in the day.

About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

Contacts
Erika Winkels
Public Relations
+1-612-558-8932

Ingrid Goldberg
Investor Relations
investor.realations@medtronic.com

SOURCE Medtronic plc

Global law firm K&L Gates has advised Australian environmental consultancy Ektimo Pty Ltd on the sale of 70% of its shares to PEMBA Capital Partners, marking PEMBA’s first investment in the environmental consulting sector.

Ektimo is a leading provider of air quality, odour, and emission monitoring services to the energy, resources, infrastructure, and manufacturing sectors – sectors facing increasingly stringent environmental and regulatory requirements amid Australia’s decarbonisation push.

The transaction, signed on 23 December 2025, positions Ektimo for accelerated growth as PEMBA partners with the company to expand its service offerings and geographic footprint.

The deal team was led by Melbourne partner Harry Kingsley, with support from senior associate Andrew Saunders, and lawyers Rami Maserow and Seb Kostas. KMPG’s Luke Lawrentschuk and Lauren Morcom acted as corporate financial advisers to Ektimo, ensuring seamless execution of this complex transaction.

Kingsley stated: “This transaction underscores the growing importance of environmental consulting as businesses navigate complex regulatory landscapes and pursue emissions reduction targets. We are proud to have supported Ektimo in achieving this milestone and thank PEMBA Private Equity for their collaborative approach throughout the process.  We look forward to seeing Ektimo accelerate its growth through this strategic partnership.”

Matthew Heskin, CEO and Co-Founder of Ektimo, said: “This partnership marks a pivotal moment for Ektimo. PEMBA’s investment will allow us to scale our capabilities, broaden our service offerings, and continue delivering industry-leading environmental solutions nationwide. We greatly appreciate K&L Gates’ guidance and support in navigating this transformative step for our development.”

K&L Gates’ Corporate practice is one of the most substantial in the legal industry, with hundreds of lawyers in offices across the globe providing clients with practical legal solutions in the structuring, financing, and completion of domestic, international, and cross-border transactions.

To learn more about this transaction, see additional coverage in the Australian Financial Review.